Petrus Lenting
10Patents
2h-index
13Co-inventors
51Inventor score
Filing activity: Dec 9, 1997 → Mar 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6919311B2 | Factor VII polypeptide having factor VII:C activity | Human Necessities | 23 | Expired |
| US6284871A | Factor IX binding peptides, derived from factor VIII and their use as inhibitors of blood coagulation | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7544660B2 | Factor VIII polypeptide having factor VIII:C activity | Human Necessities | 2 | Expired |
| US10851176B2 | Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A | Chemistry; Metallurgy | 0 | Active |
| US10544231B2 | Antibodies for the prevention or the treatment of bleeding episodes | Chemistry; Metallurgy | 0 | Active |
| US10676730B2 | Mutated factor X polypeptides and uses thereof for the treatment of haemophilia | Human Necessities | 0 | Active |
| US10626186B2 | Anti-VWF D'D3 single-domain antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11597777B2 | Antibodies for the prevention or the treatment of bleeding episodes | Chemistry; Metallurgy | 0 | Active |
| US11560436B2 | Anti-VWF D'D3 single-domain antibodies fuse to clotting factors | Chemistry; Metallurgy | 0 | Active |
| US8546332B2 | Factor VIII polypeptide having factor VIII:C activity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.